CompletedNot Applicable

Does the Use of Continuous Glucose Monitoring (CGM) in the Immediate Postpartum Period in Women With Pregestational Diabetes Admitted to the Hospital Decrease Hypoglycemic Episodes

United States39 participantsStarted 2021-06-01

Plain-language summary

This study will examine whether continuous glucose monitoring in patients hospitalized in the immediate postpartum period is more effective than traditional point of care glucose testing in identifying patients with hypoglycemia.

Who can participate

Age range18 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Patients less than 18 years of age
✕. non-English speaking patients
✕. gestational diabetes
✕. extensive skin changes/diseases that inhibit wearing a sensor on normal skin, known allergy to adhesives

What they're measuring

Number of Participants With Hypoglycemia During Postpartum Hospital Stay

Timeframe: Postpartum admission, 2-5 days

Trial details

NCT IDNCT06141941

SponsorUniversity of Iowa

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-04-30

Results submitted2025-04-23

View on ClinicalTrials.gov More Pregestational Diabetes trials